Össur Launches Rebound® ACL Knee Brace

Össur, a global leader in the orthotics and prosthetics (O&P) industry with a rich history of ground-breaking clinical innovations has launched
the REBOUND® ACL brace, which has been designed to help patients recovering from anterior cruciate ligament (ACL) injury.

Designed to dynamically reduce strain on a patient’s ACL and provide a comfortable load on their posterior thigh and anterior tibia, the REBOUND ACL brace provides clinically tested comfort that has been validated through clinical testing with load mapping data collected during daily activities1.

The brace’s proprietary Dynamic Tension System (DTS) allows for individualized, adjustable settings according to individual anatomy and rehabilitation requirements whether the patient is undergoing non-surgical conservative treatment approaches or recovering from post-op reconstruction.

A published clinical and biomechanical study has demonstrated that the REBOUND ACL releases strain on a patient’s ACL during activity and can also significantly reduce strain on the meniscus in people with ACL-deficient knees2. Another study demonstrated that the brace provides an opposing force that varies throughout knee flexion in proportion to ACL tension, an important feature of an ACL brace3.

“The REBOUND ACL’s DTS system draws upon the breakthrough work Össur conducted when it was
first developing its now gold-standard REBOUND® PCL brace, which provides truly anatomically correct dynamic loading through full range-of-motion,” Tymchenko added. “In developing our new REBOUND ACL brace, Össur’s R&D team applied our decades of experience in proven biomechanical approaches and collaborated with leading orthopaedic clinical experts to design a bracing solution that would provide a comfortable, anatomically correct dynamic load to the ACL during a patient’s healing.”

Constructed of lightweight aluminum, the REBOUND ACL brace features flexion and extension range-of-motion lockouts for enhanced patient safety, a posterior frame design that has been optimized for fit and support, and an open anterior to facilitate easier donning and doffing of the brace. The brace also features Össur’s proprietary Blue is YouTM system of intuitive patient touch points and ActiveGripTM liners with the added advantage of Össur’s anti-migration system (AMS) strapping, which further promote suspension and patient comfort. The brace is available for patients throughout North America and Europe, including custom-made options through Össur’s SmartMeasure app.

Additional clinical benefits of the REBOUND ACL brace were highlighted in the AOSSM Fellows Webinar, “High Risk and Revision ACLR: Considerations to Maximize Successful Outcomes,” featuring noted orthopaedic surgeon Robert F. LaPrade, M.D., Ph.D. of Twin Cities Orthopedics. An archived recording of the June 2020: High Risk ACL Patients webinar is available on YouTube from Össur Academy.

COVID Pandemic-Related Detraining May Increase ACL Injury Risk

ACL sprains and tears are among the most common orthopaedic conditions, with an estimated 300,000 ACL reconstructions performed in the U.S. annually. Individuals who participate in high-demand activities such as soccer, football, gymnastics, downhill skiing, and basketball are considered to be at greater risk of ACL injury4, and women tend to incur ACL injuries more frequently than men5.

As COVID-19 lockdown restrictions are lifted and people become more physically active, there is a chance of increasing rates of ACL injuries due to the potential impact of detraining – the partial or complete loss of previous physical conditioning – that occurred as gyms, sporting events, and leagues were closed during the pandemic and people became less physically active as a whole.

In recent months, clinicians have expressed concern that many people may suffer from the effects of detraining, which typically include reduced muscle mass and neuromuscular capability as well as diminished strength, speed, flexibility and endurance, and increased risk of injury when physical activities resume6.

“For 50 years, Össur has been dedicated to innovation to help people live a life without limitations.
This includes our commitment to developing therapeutic bracing and support solutions like our new REBOUND ACL brace, so that orthopaedic clinicians have the technologies they need to provide optimal care to their patients,” Tymchenko said.

The REBOUND ACL brace is now available throughout North America.

About Össur

Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that helps people live a life without limitations. A recognized “Technology Pioneer” with a rich 50-year history, Össur focuses on improving people’s mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports. Significant investment in research and development have led to over 2,000 patents, award-winning designs, successful clinical outcomes, and consistently strong market positions. Össur is signatory to the UN Global Compact, UN Women’s Empowerment Principles, contributes to the UN Sustainable Development Goals and will be carbon neutral in 2021. Össur operates globally and employs about 3,500 employees.